Johns Hopkins Diabetes Guide
Ezetimibe
INDICATIONS
FDA
FDA
- Primary hyperlipidemia
- Homozygous familial hypercholesterolemia (with statins)
- Homozygous sitosterolemia
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 4, 2019
Citation
Patel, Nisha K, et al. "Ezetimibe." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547052/all/Ezetimibe.
Patel NK, Crowder A, Margolis S. Ezetimibe. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547052/all/Ezetimibe. Accessed December 4, 2023.
Patel, N. K., Crowder, A., & Margolis, S. (2019). Ezetimibe. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547052/all/Ezetimibe
Patel NK, Crowder A, Margolis S. Ezetimibe [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2023 December 04]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547052/all/Ezetimibe.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ezetimibe
ID - 547052
A1 - Patel,Nisha,Pharm.D.
AU - Crowder,Alona,Pharm.D.
AU - Margolis,Simeon,M.D.
Y1 - 2019/06/04/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547052/all/Ezetimibe
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
